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Abstract.  Ca  2÷ ATPases deplete the cytosol of Ca  2÷ 
ions and are crucial to cellular Ca  2÷ homeostasis.  The 
PMC1 gene of Saccharomyces cerevisiae encodes a 
vacuole membrane protein that is 40%  identical to the 
plasma membrane Ca  :÷ ATPases (PMCAs) of mam- 
malian cells. Mutants lacking PMC1 grow well in 
standard media, but sequester Ca  2÷ into the vacuole at 
20%  of the wild-type levels, pmcl null mutants fail to 
grow in media containing high levels of Ca  2÷, suggest- 
ing a  role of PMC1 in Ca  ~÷ tolerance.  The growth in- 
hibitory effect of added Ca  2÷ requires activation of cal- 
cineurin,  a Ca  2÷ and calmodulin-dependent protein 
phosphatase.  Mutations in calcineurin A  or B  subunits 
or the inhibitory compounds FK506 and cyclosporin A 
restore growth of pmcl mutants in high Ca  2+ media. 
Also, growth is restored by recessive mutations that 
inactivate the high-affinity Ca2+-binding  sites in 
calmodulin.  This mutant calmodulin has apparently 
lost the ability to activate calcineurin in vivo. These 
results suggest that activation of calcineurin by Ca  2+ 
and calmodulin can negatively affect yeast growth.  A 
second Ca  ~+ ATPase homolog encoded by the PMRI 
gene acts together with PMC1 to prevent lethal activa- 
tion of calcineurin even in standard (low Ca  2+) condi- 
tions.  We propose that these Ca  ~+ ATPase homologs 
are essential in yeast to deplete the cytosol of Ca  ~+ 
ions which,  at elevated concentrations,  inhibits yeast 
growth through inappropriate activation of calcineurin. 
C  A2÷ plays a  key role in the transduction  of external 
signals  through  the cytoplasm of eukaryotic  cells. 
Fluctuations  in  the  cytosolic free Ca  2÷ concentra- 
tion,  [Ca2÷]c,  ~  directly elicit a cellular response by altering 
the  function  of  Ca2÷-binding proteins  and  their  targets. 
Resting  cells maintain  [Ca2+]c at  very low levels  against 
large  gradients  of  compartmentalized  and  extracellular 
Ca  2÷. A variety  of stimuli  can trigger  the opening  of Ca  2÷- 
specific channels in plasma membrane or endoplasmic  retic- 
ulum causing  massive Ca  2÷ influx and accumulation  in the 
cytoplasm.  After stimulation,  the basal [Ca2+]c levels are 
restored  by  Ca  2÷  ATPases  and  antiporters  that  transport 
Ca  2÷ from the cytoplasm through the plasma membrane and 
several  internal  membranes.  To regulate [Ca2÷]c and effect 
the  appropriate  responses  to  Ca  :÷  signals,  cells utilize  a 
wide array of ion transporters and sensory factors. 
Ca  2÷ signaling plays an important role in the activation of 
T  cells  (Gardner,  1989).  Binding  of antigens  to  specific 
receptors at the surface of quiescent T cells triggers the open- 
ing  of Ca  2÷  channels  in  the  endoplasmic  reticulum  and 
plasma  membrane,  leading  to  rapid  elevation  in  [Ca2÷]c. 
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1. Abbreviations used in this paper: [Ca2+]c, cystolic free Ca  2+ concentra- 
tion; SERCA, sarco/endoplasmic reticulum Ca  2÷ ATPase; PMCA, plasma 
membrane Ca  2÷ ATPase. 
The  rise  in  [Ca~+]c is  necessary  for  induction  of many 
genes including IL-2 which produces an autocrine factor re- 
quired for T cell proliferation.  Ca  2÷ dependent transcription 
is blocked by the immunosuppressive drugs cyclosporin A 
and FK506 that  act together with their respective binding 
proteins,  cyclophilin  and FKBP-12,  as potent inhibitors  of 
calcineurin  (Liu et al., 1991a). A direct role for calcineurin 
in IL-2 expression is supported by the observation that over- 
production of calcineurin  partially bypasses the requirement 
for  elevated  [Ca~+]c and  decreases  the  effectiveness  of 
FK506 and cyclosporin A (Clipstone and Crabtree,  1992; 
O'Keefe et al.,  1992).  These findings strongly  suggest that 
Ca2÷-dependent activation of calcineurin  is a crucial step in 
the activation  of T cells. 
Recent reports have extended the range  of cell types and 
species that respond to these drugs, suggesting that calcineu- 
rin  may  be  a  widespread  component  of  Ca2÷-signaling 
mechanisms.  Studies  in the budding yeast Saccharomyces 
cerevisiae indicate  that  calcineurin  is  involved  in  the re- 
sponse to mating pheromone.  Yeast cells respond to mating 
pheromones by arresting cell cycle progression transiently  in 
G1 phase and inducing  expression  of many genes involved 
in conjugation.  Cells that  have not mated after prolonged 
pheromone exposure can recover and proliferate  as long as 
sufficient  Ca  2÷  is  supplied  in  the  medium  (Iida  et  al., 
1990). Recovery is inefficient in mutants lacking calcineurin 
activity (Cyert et al.,  1991; Cyert and Thomer,  1992). The 
recovery defect of calcineurin  mutants can be mimicked in 
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(Foor et  al.,  1992).  Although  calcineurin  is  required  for 
recovery  from  pheromone  arrest,  it  is  not  essential  for 
vegetative growth under standard  conditions (Cyert  et al., 
1991;  Liu  et  al.,  1991b; Kuno  et  al.,  1991; Cyert  and 
Thorner,  1992). 
Yeast calmodulin is essential  for viability  (Davis  et al., 
1986),  but its ability to bind Ca  2+ with high affinity  is not 
necessary for vegetative growth (Geiser et al., 1991).  These 
findings  can  be  explained  by  proposing  that  any  positive 
functions  of CaWcalmodulin  and  its  targets  such  as  cal- 
cineurin are redundant  with those of other cellular factors 
during  standard growth conditions. Alternatively,  the vege- 
tative  functions of CaWcalmodulin  and  calcineurin could 
have gone undetected because the mutants were analyzed under 
conditions  where [Ca2+]c is low,  ~0.1-0.3  #M  (Halachmi 
and Eilam,  1989;  Ohya et al.,  1991). 
The functions of calmodulin and calcineurin could be bet- 
ter analyzed  if [Ca2+]c was experimentally elevated above 
the basal levels. A way to accomplish this is by genetically 
manipulating  the ion transporters  involved in Ca  2+ homeo- 
stasis.  The PMRI gene  product,  a  member  of the  sarco/ 
endoplasmic  reticulum  (SERCA)  family  of Ca  2+ ATPases 
(Serrano,  1991),  is thought to directly transport  Ca  2+ into 
the Golgi complex to support a variety of secretory functions 
(Rudolph et al.,  1989;  Antebi and Fink,  1992).  The ability 
ofpmrl mutants  to tolerate variations  in external Ca  ~+ sug- 
gests that additional Ca  ~+ transporters  might be more im- 
portant  for controlling  [Ca2+]c. The  PMR2 gene  product 
identified previously (Rudolph et al., 1989) is not related to 
known Ca  ~+ ATPases any more than H + or Na+/K + ATPases 
(Serrano,  1991)  and is required  for Na  + tolerance (Haro et 
al.,  1991) but not Ca  ~+ tolerance (K.  W. Cunningham,  un- 
published  data).  However,  a  low-affinity  H+/Ca 2+ antiport 
activity is present in isolated vacuole membranes (Ohsumi 
and Anraku,  1983).  Most  eukaryotic  cells also express a 
plasma membrane Ca  2+ ATPase (PMCA)  that is primarily 
responsible  for maintaining  [Ca2+]c submicromolar levels 
(Carafoli,  1992). 
This study  reports  the identification of the PMC1 gene, 
which encodes a homolog of mammalian PMCAs,  Genetic 
analysis  suggests that the product of PMC1 (Pmclp) trans- 
ports Ca  ~+ into the vacuole and participates  in the control of 
[Ca2+]c together  with Pmrlp.  High external Ca  ~+ inhibits the 
growth of pmcl mutants because calcineurin becomes acti- 
vated  by Ca2+/calmodulin.  Thus,  CaWcalmodulin and cal- 
cineurin  perform  at  least  one  function  that  prevents  cell 
proliferation under these conditions.  Genetic manipulation 
of PMC1 provides a valuable new approach to resolve the na- 
ture and functions of Ca  :÷ signals. 
Materials and Methods 
Recombinant DNA 
All procedures  with recombinant DNA were performed  using Escherichia 
coli strain DH5ot grown in Luria Broth medium with appropriate antibiotics 
(Maniatis  et  al.,  1982).  Protocols  used  for polymerase  chain  reaction 
(Boehringer-Mannheim,  Mannheim,  Germany)  and  sequencing  (United 
States Biochemicals, Cleveland,  OH) were performed  according to manu- 
facturer's directions. Plasrnid vectors were obtained from P. Hieter (Sikorski 
and Hieter,  1989). 
The PMC1 gene was identified by PCR amplification  of genomic DNA 
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Figure 1. Chromosomal location and DNA sequence of the PMC1 
gene. (A) A schematic  representation  of the genomic PMC1 locus 
showing the PMC1- and PMA/-coding  regions (boxes)  and partial 
restriction map. B, BglII; H, HindlII; Xb, Xbal; JO~, XhoI; A, sites 
used for constructing pmcl  :  :  LEU2 and pmcJ  : :  TRP1 mutants. Approxi- 
mately 2 kb of unsequenced  DNA between PMA/and PMC1 is indi- 
cated by a dashed line (Serrano et al.,  1986).  (B) DNA sequence 
of the 4.881-kb  HindIII fragment containing  PMC1 and predicted 
amino acid sequence of Pmclp.  Initiation and termination  codons 
are predicted at nucleotides  579 and 4,098. A potential TATA box 
(TATATA) occurs at nucleotide 481. (C) DNA and deduced protein 
sequence of the PMCI::HA open reading flame which contains  a 
96-bp insertion  in the XbaI site at codon +2. The sequence data 
are available from EMBL/GenBank/DDBJ under accession num- 
ber U03060. 
from thepmrl::LEU2  pmr2::URA3 swain IA420 using degenerate oligonu- 
clentides corresponding  to the most highly conserved regions of known 
P-type ATPases (Fig.  1). 30 cycles of amplification  (94, 45, and 72°C, each 
for 1 min) using the primer families A1 (C~TCCGTNATNTGYWSN- 
GAYAARACNGGNAC)  and  B1  (CGGAATTCGSRTCRTTNRYNCCR- 
TCNCCNG) produced a novel 1.2-kb product distinct from the 0.8-kb prod- 
uct from PMA/and PMA2 (Serrano et al.,  1986;  Schlesser et al.,  1988). 
This product was cloned into the EcoRV site of pRS303 (HIS3) forming 
plasmid pKC38. Partial sequencing  of this fragment revealed an open read- 
ing frame homologous to Ca  2+ ATPases but not identical to any previously 
reported yeast gene. This fragment was used to map the PMCI locus near 
the PMA/gene on chromosome VII (see Fig.  1) by hybridization to an or- 
dered library of genomic DNA (Riles et al., 1993). The entire PMC1 locus 
was subcloned  from plasmid B1157 containing PMA/(Serrano et al., 1986) 
as a 4.9-kb HindllI fragment into pRS315 (CENLEU2) forming pKC44 and 
pKC45  (both orientations).  A series of nested deletions in these plasmids 
were generated  by limited ExoIH/ExoVlI nuclease digestion according  to 
manufacturer's specifications  (GIBCO-BRL,  Gaithersburg,  MD). 
The integrating plasmid pKC55,  used to create a chromosomal PMCI:: 
HA epitope-tagged  allele, was constructed by transferring a 1.7-kb fragment 
of pKC45 (containing the 5' end of PMC1) into pRS306 (URA3) and subse- 
quently  inserting  a 96-bp fragment  (Fig.  1 C) encoding three tandem  re- 
peats of the HA epitope YPYDVPDYA recognized by 12CA5 monoclonal 
antibody into the XbaI site at codon +2. The construction  was verified by 
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chromosomal PMC1 locus leaving full-length  PMCI::HA adjacent to a trun- 
cated pmd::URA3 allele.  Plasmid pKC60 contains the complete epitope- 
tagged PMCI::HA gene (from HindHI to BgllII at position 4,630) in the high 
copy vector B2205 which is a derivative of pRS306 containing a 2-pm ori- 
gin of replication.  Both single copy and high copy PMCI::HA alleles pro- 
duced immunoreactive polypeptides and functionally complemented pmcl 
mutations for growth in high Ca  2+ media. The plasmid pKCll contains the 
PMRI locus (4.4-kb PvulI to SpeI fragment) from pL149 (Rudolph et al., 
1989) inserted into 132205 (2 ~  URA3) digested  with SmaI plus XbaI. 
The plasmids pKC52 and pKC59 used to replace the chromosomal PMC1 
gene with pmcl::LEU2 and pmcl::TRP1, respectively,  were constructed by 
three part ligations of the 0.58-kb HindlII/XbaI fragment and 0.88-kb XhoI/ 
HindI~ fragment of pKC45 into pRS305 and pRS304 digested  with Xbal 
and XhoI. The plasmids were linearized before yeast transformation using 
HindlH (pKC52) or using StuI plus BgllI (pKC59). pKC38 was linearized 
with NruI to form the pmcl::HIS3  disruption. 
The plasmid pKC'/3 is a derivative of pRS316-Gal (CEN ARS URA3) con- 
taining the GAL/ promoter region fused to the truncated CNAIAC allele 
which was amplified by PCR from W303-1A genomic DNA (from nucleo- 
tide -10 to nncleotide +1,350 relative to the initiation codon), terminating 
after codon 450 just before the putative calmodulin binding and autoinhibi- 
tory domains (amino acid residues 454-553) (Cyert et al., 1991; Liu et al., 
1991b). The natural COOH-terminal domain was  restored in pKC74 by 
replacing the 3' segment from SalI to Hindl]I in the polylinker with a frag- 
ment from pCNA1-201 (Cyert et al.,  1991) from SalI to HindlII in the 3' 
noncoding region. Both pKC73 and pKC'/4 complemented cnal cna2 dou- 
ble mutants in media containing galactose but not glucose (see Fig.  8). 
Yeast Strains, Media, and Growth Conditions 
Yeast strains were grown in standard YPD medium (2 % Difco yeast extract, 
1% bacto-peptone, 2% dextrose)  or YPD, pH 5.5, containing 5 mM suc- 
cinic acid and supplemented with 200 mM CaC12 when indicated in the 
text.  SC-ura  and SCGal-ura media  (Sherman et al.,  1986)  were  sup- 
plemented with 400 mM CaC12 when indicated in the text. 
Strain I.,4420 was derived from a cross between strains AA274 (Antebi 
and Fink,  1992) and YR86  (Rudolph  and Fink,  1990).  All yeast strains 
listed in Table I are derived from the isogenic strains W303-1A and W303-1B 
(Wallis et al., 1989) by transformation using the lithium acetate procedure 
or by standard genetic crosses among isogenic derivatives (Sherman et al., 
1986).  The pmcl::HIS3, pmcl::LEU2,  and pmcl::TRPl  null alleles  were 
produced in W303-1A or W303-1B as described above from lineafized plas- 
raids pKC38,  pKC52,  and pKC59.  All three alleles  produced identical 
phenotypes and are referred to as pmcl in the text. 
Thepmrl::H1S3  null allele was introduced using pLll7, a derivative of 
pLll9 (Antebi and Fink, 1992). Construction of cnal::hisG, cna2::HlS3, 
and cnbl::LEU2 null mutants was performed as described (Cyert et al., 
1991; Cyert and Thorner,  1992).  The fprl::URA3  allele was introduced 
using plasmid pYJH30 (Heitman et al., 1991). Strains JGY41 (cmd/-3) and 
JGY148 (cmd/-6) containing the 3E-V+3D-N,  and 3E-V mutations, respec- 
tively  (Geiser  et  al.,  1991),  were  derived  from  W303-1A and kindly 
provided by J. Geiser and T. Davis, Univ. of Washington, Seattle, WA. Stan- 
dard genetic crosses were used to create some strains containing multiple 
mutations. In such crosses, the phenotypes of all ascospores in a tetrad were 
tabulated and found to be uniformly consistent for each genotype. 
Spontaneous  revertants of pmcl were obtained by selection for growth 
of K473 (MATc~  pmcl::LEU2) and K482 (MATc~  pmcl::TRP1) on YPD pH 
5.5, agar medium supplemented with 200 mM CaCI2. Independent rever- 
tants were picked after 5 d at 30°C, purified, and placed into complementa- 
tion groups by mating the K473 and K482 derivatives in all combinations, 
selecting for diploids on SC-Leu-Trp, and assaying for growth on YPD, pH 
5.5, plus 200 mM CaC12 or SC-Leu-1"rp plus 400 rnM CaC12. In this way, 
three complementation  groups were identified among 42 independent  reces- 
sive revertants.  Based on genetic linkage and complementation testing, the 
first group of calcium-resistant mutants, termed crmJ,  defines the CNB1 
gene (Cyert and Thorner, 1992). The crm2 and crm3 groups (11 and 3 mem- 
bers, respectively)  are not complemented by pTD59 containing the CMD1 
gene (Geiser et al.,  1991) and will be described in future reports. 
Measurement of  Exchangeable and 
Nonexchangeable Ca  2÷ 
Yeast cultures growing exponentially  in YPD medium containing 0.18 mM 
Ca  2+ (Ohya et al., 1984) were shifted to fresh YPD medium supplemented 
with 45Ca  2+ (41 cpm/pmol) and grown at 30°C for 6.5 h to a final ODt00 
of 1.5 (7.5  x  107 cells/ml).  The total cell-associated  Ca  2+ was calculated 
by measuring the radioactivity recovered from 0.1-ml culture aliquots which 
were diluted into 5 ml ice-cold buffer A (5 mM Na-Hepes,  pH 6.5, 10 mM 
CaCI2), filtered rapidly onto 24 rnm Whatman GFF filters using a multiple 
vacuum filtration unit (model HV224,  Hoefer Sci. Instrs., San Francisco, 
CA),  washed three times with ice cold buffer  A,  dried in vacuo,  and 
Table L  List of Yeast Strains 
Strain  Genotype*  Source~; 
W303-1A 
W303-1B 
JGY41 
JGY148 
K444 
K445 
K470 
K473 
K473 -a7 
K482 
K484 
K510 
K541 
K557 
K559 
K603 
K605 
K607 
K610 
K612 
K614 
K616 
MA Ta 
M  A Tu 
MATa cmdl-3 
MATa cmdl-6 
MATa pmcl :  :HIS3 
MATa cmdl-6 pmcl ::HIS3 
MATa PMCI  :  :HA  (pmcl ::URA3) 
MATa pmcl :  :LEU2 
MATa pmcl :  :LEU2  cnb l-1 
MATer pmc  l :  :  TRP1 
MA  Ta pmc  l :  :  LE  U2 fpr  l :  : URA3 
MATa pmcl :  :LEU2  cmdl-3 
MATa pmcl :  :LEU2  cna2: :HIS3 
MA  Ta pmc  l :  :  LE  U2 cna l :  :  hisG 
MATa pmcl::LEU2 cnal::hisG cna2::HIS3 
MA  Ta cnb l :  :  LE  U2 
MA  Ta pmc  l :  :  TRP1 
MA  Ta pmc  l :  :  TRP1  cnb l :  :  LE  U2 
MATu pmrl: :HIS3 
MATu pmrl :  :HIS3 cnb l :  :LEU2 
MATc~ pmrl::HIS3 pmcl::TRP1 
MA  Tu p mr  l :  :  HIS  3 pmc  l :  :  TRP1  cnb l :  :  LE  U2 
Wallis et al.,  1989 
Wallis et al.,  1989 
Geiser et al.,  1991 
Geiser et al.,  1991 
W303-1A 
JGY148 
W303-1A 
W303-1A 
K473 
W303-1B 
K473 
* All strains harbor the following additional mutations: are2-1 canl-lO0 his3-11,15 leu2-3,112 trpl-I ura3-1. 
¢ Strains K444 through I(484 were constructed by transformation of the source strain.  Strains I(510 through K616 were produced by crossing derivatives of 
W303-1A, W303-1B, and JGY41 which contained mutations in cnal,  cna2, or cnbl  that were introduced by transformation. 
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pools were determined by the same procedure except  that each culture was 
first diluted 10-fold into prewarmed YPD medium supplemented with 20 
mM CaCI2 (a 1,000-fold isotopic dilution) and incubated an additional 20 
rain before filtration. The radioactivity released from the cells by this 
equllihration procedure represents the exchangeable  Ca  2"+ pool, which was 
calculated as the difference between the total cell-associated Ca  2"+ and the 
nonexchangeable  Ca  2+. All measurements  were performed in duplicate and 
averaged. 
Miscellaneous Procedures and Reagents 
DAPI and immunofluorescent  stainings were performed as described (Prin- 
gle et al.,  1991) on early log phase cultures growing in SC-ura medium at 
30"C. SDS gel electrophoresis (Laemmli, 1970) and Western blots (John- 
son et al.,  1984) were performed on total cell lysetes (Reid and Schatz, 
1982) prepared from equivalent  numbers of  log phase cells grown in SC-ura 
medium. CaCI2 (C-7902; Sigma Immunochemicals, St. Louis, MO) and 
4~CaC12 (Amersham Corp., Arlington Heights, IL) were used to supple- 
ment growth  medium. FK506 was a generous gift from Vertex  Pharmaceuti- 
cals, Inc. (Cambridge, MA). Cyclosporin A was provided by H. Lodish 
(Whitehead Institute, Cambridge, MA). All other reagents were commer- 
cially available. 
Results 
Cloning and Expression of  a Yeast Homolog of  PMCA 
Our  strategy  to  control  calcium  signaling  in  yeast was  to 
identify and manipulate the genes encoding the Ca  :'+ trans- 
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Figure 2. Alignment of the predicted PMC1 gene product (top se- 
quence) with rat  PMCAla (bottom sequence, [$hull  and  Greeb, 
1988]).  Gaps (-) were introduced to maximize homology (Lipman 
and Pearson, 1985). Predicted transmembrane domains 1-10 are in- 
dicated by underline and overline. Arrowheads (A) mark the highly 
conserved catalytic autophosphorylation and ATP-binding domains 
employed in the design of degenerate oligonucleotides  for PeR 
analysis. 
porters.  Ca  2+ ATPases  are members of a  highly  conserved 
family of P-type ion pumps, all of which contain highly con- 
served phosphorylation and ATP-binding domains (Fig.  2). 
At  least  five  different  yeast  genes  contain  both  these  se- 
quence motifs, as suggested by PCR analysis (see Materials 
and Methods).  Four of these PeR products encode portions 
of the previously identified PMAI, PMA2, PMRI, and PMR2 
genes.  A  novel  1.2-kbp PeR  product that comigrates with 
the PMR2 product was cloned after amplification of genomic 
DNA  from  a pmrl pmr2  deletion  strain.  This  clone  con- 
tained an open reading frame highly homologous to a  seg- 
ment  of  mammalian  PMCAs.  The  DNA  segment  was 
mapped by hybridization  to chromosome VII very close to 
the PMAI gene (Fig.  1 A),  and defined a  new gene termed 
PMC1 based on its homology to PMCAs. 
The entire PMC1 gene was subcloned from plasmid B1157 
(see Fig.  1 A), which had been isolated previously in this lab- 
oratory during the cloning of PMA1, the major H + ATPase 
in the plasma membrane (Serrano et al.,  1986). A long open 
reading frame of 1,173  codons encompassing the PCR prod- 
uct (Fig.  1 B) predicts a  131-kD polypeptide showing 41% 
identity  with  rat PMCAla  (Shull  and  Greeb,  1988),  about 
40 % identity with other PMCA isoforms, and less than 24 % 
identity  with  SERCA  and  other  known  P-type ion pumps. 
Alignment of the predicted protein sequence Pmclp with rat 
PMCAIa  (Fig.  2)  shows  similarity  through  all  10 putative 
transmembane  domains  (M1-M10)  and  most  hydrophilic 
regions  except for the  NH2- and  COOH-terminal  domains 
as well as several apparent insertions and deletions. The ma- 
jor structural differences occur in regulatory regions that are 
not  well  conserved  among  the  known  PMCA  isoforms 
(Carafoli,  1992).  The large insertion and deletion in PMCI 
between M2 and M3 occur in a phospholipid binding regula- 
tory region that is subject to alternative splicing in various 
PMCA  isoforms.  Interestingly,  a  COOH-terminal  domain 
that is present  in most PMCA  isoforms and is involved in 
calmodulin  binding  and  autoinhibition  is absent  in  Pmclp 
and  replaced  by  a  much  smaller  COOH-terminal  domain 
lacking  significant  similarity  to  other  proteins  in  current 
databases.  Despite  these  structural  differences,  PMC1 ap- 
pears to retain all conserved features of P-type ATPases and 
is the first reported  fungal homolog of PMCA. 
The  product  of PMC1  is  expressed  during  exponential 
growth  as  judged  by  immunoblotting  (Fig.  3)  and  im- 
munofluorescence  microscopy  (Fig.  4).  For  these  experi- 
Figure 3.  Immunoblot analysis of Pmclp. 
Total cell lysates prepared from exponen- 
tially grown strains W303-1A PMC1 (lane 
1) or K470 PMCh:HA (lane 2) were frac- 
tionated by SDS-PAGE  on 7.5%  gels and 
analyzed by immunoblot using a 1:1,000 dilu- 
tion of 12CA5 monoclonal antibody which 
binds specifically to HA epitopes. Immune 
complexes were visualized on radiographic 
film (Kodak) using the ECL chemiIlumines- 
cence  detection  kit.  Protein  molecular 
weight  markers  loaded  in  adjacent  wells 
were marked after Ponceau S staining of  the 
nitrocellulose blot prior to treatment with 
blocking agents. 
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cence localization of Pmclp to 
vacuole  membranes.  W303- 
1A  strains  transformed  with 
the high copy plasmid pKC60 
(top),  the integrating plasmid 
pKC55 (center), or the control 
plasmid B2205 (bottom) were 
grown  to  early  log  phase, 
fixed, and processed for immu- 
nofluorescence  microscopy 
using the  12CA5 rnonoclonal 
antibody. The PMCI:  :HA prod- 
uct is visible at the vacuole pe- 
riphery in overexpressing  strain 
(top) and the single copy strain 
(center),  but only nonspecific 
background staining is visible 
in  similar  exposures  of the 
strain lacking the epitope. No- 
marski microscopy and DAPI 
staining identify the vacuoles 
and nucleus, respectively. 
menU, the PMCI::HA gene product was visualized using the 
12CA5 monoclonal antibody, which recognizes a 34-amino 
acid insertion at codon +2 in the PMC1 open reading frame 
(Fig.  1 C).  This epitope-tagged version of PMC1  is func- 
tional in vivo when integrated into its chromosomal locus or 
when expressed from high copy plasmids (see below). Im- 
munoblotting  of total  cell  lysates  revealed  a  major  im- 
munoreactive polypeptide at '~130 kD, in good agreement 
with the predicted molecular mass of 131 kD (Fig. 3, lane 
2).  Only  minor  cross-reacting species  were  observed  in 
Cunningham and Fink Ca  z+ Transport and Signaling in  Yeast  355 lysates prepared from strains  lacking the  epitope  (Fig.  3, 
lane 1 ). 
Analysis  by  immunofluorescence  microscopy  revealed 
that the epitope-tagged PMCI::HA gene product is localized 
predominantly  to  vacuole  membranes  in  log-phase  cells 
(Fig.  4).  Cells producing  the PMCI::HA product from its 
chromosomal locus displayed staining of one to three large 
vesicular structures corresponding to vacuoles by Nomarski 
optics. Expression of PMCI::HA from a multi-copy plasmid 
greatly increased the staining of the vacuole periphery. No 
staining of the nucleus,  endoplasmic reticulum,  mitochon- 
dria,  or  plasma membrane was  detected  in  these  experi- 
ments. These results suggest that the PMC1 product might 
function  to transport Ca  2+ ions  into  the vacuole from the 
cytosol. High affinity Ca  2+ ATPase or Ca  2+ transport activi- 
ties have not yet been detected in vacuole membrane vesicles 
(Ohsumi and Anraku,  1983). 
Pmclp Sequesters Ca  2+ In Vivo 
The effects of mutating the chromosomal PMC1 gene were 
examined to infer its function in yeast. The PMC1 gene is not 
essential for viability since deleting 97 % of the PMC1 open 
reading frame (Fig.  1 A) had no significant effect on growth 
rate in rich or synthetic media at a variety of temperatures. 
Additionally, disruption of PMC1 does not noticeably affect 
mating,  sporulation,  starvation,  or  a  variety of other  re- 
sponses. These observations show that the function of PMC1 
is not required for the execution of many processes under 
standard conditions. 
The effect of deleting PMC1 on  steady state Ca  2+ pools 
suggests that Pmclp functions in Ca  2+ sequestration in vivo. 
The yeast vacuole accumulates over 95 % of the total cell- 
associated  calcium  (Eilam  et  al.,  1985),  the  majority  of 
which is nonexchangeable in pulse/chase experiments (Ei- 
lain,  1982a,b).  Accordingly,  the exchangeable and nonex- 
changeable  Ca  2+  pools  were  measured  in  exponentially 
growing PMC1 and pmd cells. The exchangeable Ca  2÷ pool 
was increased only slightly (12%) in pmcl cells relative to 
wild-type cells. However, the nonexchangeable Ca  2+ pool in 
pmcl cells was over fivefold lower than that of isogenic wild- 
type cells (Fig. 5). This difference reflects a large reduction 
in the vacuole Ca  2+ pool in pmcl mutants, and suggests that 
Pmclp is necessary for efficient Ca  2+ sequestration in vivo. 
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Figure 5.  Ca  2+ compartmen- 
talization  in wild-type, pmcl, 
and pmcl  cnbl strains.  The 
exchangeable (black) and non- 
exchangeable  (striped) pools 
of cells associated Ca  2+ were 
measured  in strains W303-1A 
(WT),  K605  (prod),  and  K607 
(pmcl cnbl) using  cells  uni- 
formly  labeled  with  45Ca2+ 
(41 cpm/pmol) as described in 
Materials  and  Methods.  The 
values shown are the average 
of  duplicate  experiments. 
(SEM less than 5 % of  the total 
for each determination). 
Figure 6.  Growth and morphology of pmd mutants in high Ca  2+ 
media. Cultures ofW303-1A (WT), K603 (cnbl), K605 (pmc/), and 
K607 (pmcl cnbl) growing exponentially in YPD, pH 5.5, medium 
were collected by centrifugation and suspended in YPD, pH 5.5, 
medium supplemented with 200 mM CaC12 and shaken at 30°C. 
(A) The relative optical density at 600 nm (normalized to the initial 
level) was determined for each culture at the indicated time inter- 
vals.  To maintain  low cell  densities,  serial  dilutions  into  fresh 
prewarmed media were made as necessary and factored into the cal- 
culation of relative optical density. (B) Nomarski micrographs of 
pmcl  mutants  growing  for 24  h  in  YPD  medium  (top) and  in 
YPD+200 mM Ca  2+ (center) and of W303-1A growing for 24 h in 
YPD+200 mM Ca  2+ (bottom). 
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As pmcl mutants have decreased ability to sequester Ca  2+ 
in the vacuole, we tested their ability to tolerate very high 
or  very low  Ca  2+  concentrations  in  the  growth  medium. 
Wild-type and pmcl null mutants are indistinguishable dur- 
ing growth in synthetic media containing <1/~M Ca  2+ (Ru- 
dolph et al.,  1989) or in complex YPD media containing 
varying amounts of EGTA (not shown). However, pmcl null 
mutants grow very poorly in YPD medium, pH 5.5,  sup- 
plemented with 200 mM CaC12 (Figs. 6 and 7). The growth 
defect ofpmcl mutants was not observed in YPD, pH 5.5, 
supplemented with 200 mM MgC12 (Fig.  7).  Additionally 
Ca  :+ sensitivity was not observed in strains expressing only 
the epitope-tagged PMCI::HA hybrid from its chromosomal 
locus or from high copy plasmids (not shown). These obser- 
vations demonstrate that PMC1 is necessary for tolerance to 
high  Ca  2+  and  confirm the  importance of the  vacuole in 
yeast Ca  :+ homeostasis (Klionsky et al.,  1990;  Anraku et 
al.,  1991). 
In  liquid  growth  medium  supplemented with  200  mM 
Ca  2+, wild-type strains grew exponentially after a brief lag 
(Fig. 6 A). In contrast, pracl mutants shifted to high Ca  :+ 
media increased culture density at a slow linear rate that con- 
tinued over at least 32 h. After 24 h of incubation, the optical 
density oftheprad culture increased 10-fold and the number 
of  viable cells increased approximately 5-fold, as determined 
by colony forming units on agar YPD, pH 5.5, medium sup- 
plemented with 200 mM MgC12. Though the morphology 
of pmcl cells changed somewhat during incubation in high 
Ca  2+  (Fig.  6  B),  they did not accumulate with a  uniform 
morphology. Thus, the growth inhibition ofprad mutants by 
high Ca  :+ is reversible and apparently not a consequence of 
a specific block in the cell division cycle. 
Calcineurin Mediates Growth Inhibition of  pmcl 
Mutants in High Ca  2÷ Medium 
The mechanism by which external Ca  2÷ inhibits the growth 
of pmcl mutants was investigated by characterizing sponta- 
neous revertants carrying secondary mutations that restore 
the ability of pmcl null mutants to proliferate in high Ca  2+ 
media (see Materials and Methods). Recessive mutations in 
three complementation groups  were found to  reverse the 
Ca  2+ sensitivity of pmcl mutants.  The first group of rever- 
tants (termed crm/ for Ca  2+ resistant mutation) was found 
to define the CNB1 gene which encodes the Ca  2+ binding 
regulatory subunit of calcineurin (Kuno et al.,  1991; Cyert 
and Thorner, 1992). The crm/alleles displayed a defect in 
recovery from pheromone arrest similar to cnbl null mutants 
(Cyert and Thorner,  1992), were genetically linked to the 
CNB1 locus  (44:0:0,  parental  ditype/non-parental ditype/ 
tetratype), and were complemented by plasmids carrying the 
wild-type CNB1 gene. Additionally, disruption of CNB1 by 
gene replacement restores growth ofpmcl mutants (Fig. 7). 
Growth ofpmcl mutants is also restored by simultaneous de- 
letion of both genes encoding the catalytic subunit of calci- 
neurin, CNA1 and CNA2 (Fig. 7). Deletion of either CNAI 
alone or CNA2 alone is not sufficient to suppress the Ca  2÷ 
sensitivity ofpmcl. By this assay, the CNAI and CNA2 genes 
are functionally redundant,  which explains why no spon- 
taneous cna/or cna2 mutants were recovered in the initial 
Figure 7. Growth inhibition of pmcl by high Ca  2+ is prevented by 
mutations in calmodulin and calcineurin. Yeast strains were spread 
onto the surface of YPD agar medium, pH 5.5, supplemented with 
either 200 mM CaC12 (.4) or 200 mM MgCI2 (B) and incubated at 
30°C for 3 d. Strains clockwise from top: W303-1A, K473, K473- 
a7,  K607, K541, K557, K559, and  K510  with  relevant  geno- 
types (C). 
Cunningham and Fink Ca  2+ Transport and Signaling in Yeast  357 revertant screen. Loss of calcineurin function did not affect 
growth ofpmcl mutants in standard media or in media sup- 
plemented with 200 mM MgCI~. Thus, growth inhibition of 
pmcl mutants by high Ca  2+ requires the function of both the 
catalytic and regulatory subunits of calcineurin. 
In high Ca  2÷ liquid media (Fig. 6 A), cnbl and pmcl cnbl 
strains grow at faster rates (1.6 h doubling time) than an iso- 
genie wild-type strain (2.5 h doubling time). This result sug- 
gests that calcineurin activity limits the rate of yeast growth 
in high Ca  2+ conditions, and is consistent with earlier ob- 
servations that the CNAI, CNA2, and CNB1 genes are not re- 
quired for vegetative growth in standard media (Cyert et al., 
1991; Liu et al.,  1991b; Cyert and Thorner, 1992). Interest- 
ingly, pmcl cnbl mutants have a larger pool of nonexchange- 
able Ca  2÷ than pmcl mutants (Fig. 5). If Ca  2+ sequestration 
into the vacuole is improved by inactivation of calcineurin, 
this might explain the enhanced growth rate of pmcl  cnbl 
(and cnbl) strains in high Ca  2÷ media. 
Activation of Calcineurin by CaZ+/Calmodulin Is 
Necessary for Inhibition of  pmcl Mutants 
The protein phosphatase activity of manunalian calcineurin 
in vitro is  greatly stimulated by binding of Ca  2* and  cal- 
modulin (Stewart et al.,  1982). Similarly, calmodulin binds 
to the CNA1 and CNA2 gene products only in the presence 
of Ca  2+  (Cyert et  al.,  1991;  Liu  et  al.,  1991b).  Mutant 
forms of calmodulin that are unable to bind Ca  2+ fail to ac- 
tivate target enzymes in vitro (Hurwitz et al., 1988), but still 
provide functions necessary for yeast viability (Geiser et al., 
1991).  Using  cmdl-3 strains,  which express a  calmodulin 
mutant containing two amino acid substitutions in each of 
Figure 8. Expression of COOH-terminal truncated CNA1 (CNA1AC)  bypasses cmdl-3 inpmcl mutants. Strains K473 (lines I and 2), KSI0 
(lines 3 and 4), K559 (lines 5 and 6), and K607 (lines 7 and 8) were transformed with low copy plasmids containing derivatives of CNAI 
(pKC74, lines 1, 3, 5, and 7) or CNAIAC (pKC73, lines 2, 4, 6, and 8) under control of the galactose-inducible promoter of GALL Strain 
KS10 (lines 9 and 10) was also transformed with a control plasmid pUN50, or pTD59 containing the CMD1 gene (Geiser et al.,  1991). 
Strain K473 was also transformed with the high copy control plasmids B2205 or pKC11 containing the PMRI gene. Serial fivefold dilutions 
of saturated cultures were spotted onto complete medium lacking uracil (to maintain selection for the plasmids) supplemented with the 
2% glucose or galactose and 400 mM CaClz as indicated. The plates were photographed after 3 d incubation at 30°C. High Ca  2+ inhibits 
growth of pmcl cmdl-3 and pmcl cnal cna2 but not pmcl crrbl mutants expressing CNAI  AC. High Ca  2+ does not inhibit growth of pmcl 
cmdl-3 or pmcl cnbl mutants expressing CNA1. 
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to test whether Ca  2÷ binding to calmodulin is necessary for 
growth inhibition of pmcl  mutants by high Ca  2÷. 
In contrast topmcl mutants, apmcl cmdl-3 double mutant 
grows well on high Ca  2÷ media (Fig. 7). Introduction of a 
low copy plasmid carrying the wild-type CMD1 gene into the 
pmcl cmdl-3 strain restored Ca  2÷ sensitivity (Fig. 8, lines 9 
and 10), indicating that the mutant calmodulin has not gained 
a  function (dominant over wild type), but rather has spe- 
cifically lost a  function required for Ca2÷-induced  growth 
inhibition. Identical results were obtained with apmcl::HIS3 
cmdl-6 strain (K445), which contains only three point muta- 
tions in the CMD1 gene (data not shown). Thus, a mutant 
with amino acid substitutions in the high affinity Ca  2÷ bind- 
ing sites of calmodulin has the same phenotype as a mutant 
that has lost calcineurin function. 
Ca2÷/calmodulin  activates calcineurin in vitro by binding 
to a  COOH-terminal domain of the catalytic subunit and 
relieving autoinhibition by this domain (Stewart et al., 1982; 
Hashimoto et al.,  1990). Proteolytic removal of the autoin- 
hibitory domain causes calmodulin-independent stimulation 
of protein phosphatase activity (Manaian and Klee, 1983). 
These biochemical data predict that a CNAI truncation mu- 
tant lacking the autoinhibitory domain would become acti- 
vated independent of Ca2+/calmodulin  and  would  prevent 
growth  of pmcl  cmdl-3 strains  in  high  Ca  2÷  media.  As 
predicted,  a pmcl  cmdl-3 strain expressing the truncated 
CNAIAC allele from an inducible promoter (GAL/) fails to 
grow in high Ca  2÷ medium (Fig. 8, line 4). In contrast, ex- 
pression of wild-type CNA1 from this promoter does not in- 
hibit growth of the pmcl cmdl-3 strain in high Ca  2÷ medium 
(Fig. 8, line 3). The GAL/- induced expression of CNA1 and 
CNA1AC does not inhibit growth of yeast strains in the ab- 
sence of added Ca  2÷ (not shown). Furthermore, expression 
of either CNA1 or CNA1AC inhibits growth of a pmcl cnal 
cna2 strain (Fig. 8, lines 5 and 6) but not a pmcl cnbl strain 
(lines  7 and  8)  in  high  Ca  2÷ media.  Thus,  removing the 
COOH-terminal  autoinhibitory  domain  of calcineurin  A 
specifically bypasses the requirement for Ca2+/calmodulin 
to promote growth arrest,  though calcineurin B  and Ca  2+ 
are  still  required for this  arrest.  These data  suggest that 
the major role of Ca2+/calmodulin  in growth inhibition by 
Ca  2+ is to activate calcineurin via its COOH-terminal region. 
The cmdl-3 mutant calmodulin is  unable to perform this 
function. 
FKS06 and Cyclosporin A Inhibit Yeast Calcineurin 
In Vivo 
The immunosuppressant drug FKS06 binds tightly to a com- 
plex of proteins present in wild-type yeast strains and absent 
in extracts made from strains  lacking calcineurin A,  cal- 
cineurin B, or the yeast homolog of FKBP-12 encoded by 
FPR1 (Foor et al., 1992). A similar complex formed in mam- 
malian cells results in the complete inhibition of calcineurin 
activity  towards  phosphopeptide  substrates  (Liu  et  al., 
1991a).  These considerations prompted us to test whether 
FK506 would restore growth ofpmcl mutants in high Ca  2+ 
media by inhibiting yeast calcineurin. 
Addition of FK506 dramatically restores growth of pmcl 
mutants  in high  Ca  2÷ medium,  but has no effect on pmcl 
fprl  strains lacking FKBP-12 (Fig.  9 A). In this assay,  the 
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Figure 9. FK506 (A) and cyclosporin A (B) suppress the Ca  2+ sen- 
sitivity ofpmcl mutants. Yeast strains (Table I) were inoculated at 
low density into YPD medium, pH 5.5, supplemented with 200 
mM CaCI2 and the indicated concentrations of FK506 (A) or cy- 
closporin A (B). After 24 h incubation at 30°C in fiat bottom mi- 
crotiter dishes, the optical density of each culture was measured at 
570 nm (GR600 Microplate Reader; Dynatech Labs. Inc., Chan- 
tilly, VA). The effect of FK506 but not cyclosporin A requires func- 
tional FPRI. The effective dosages of both drugs correlate with the 
gene dosage of CNA. 
50% effective dosage (EDs0) of FK506 was estimated at 25 
ng/ml which is over 1,000 times lower than the 50% lethal 
dosage (LDs0) of ,,050 #g/ml (Heitman et al.,  1991).  There 
is also a direct correlation between the effectiveness of the 
drug and the dosage of calcineurin A genes, pmcl cnal and 
pmcl cna2 double mutants each required approximately half 
as  much  FK506  (12  ng/ml)  when compared to  the pmcl 
strain. These results fully support the hypothesis that a direct 
target of FK506/FKBP-12 in yeast is activated calcineurin. 
Cyclosporin A,  a  structurally distinct inhibitor of cal- 
cineurin acting through its own binding protein (Liu et al., 
1991a),  also restores growth of pmcl  mutants in high Ca  2÷ 
media (Fig. 9 B). The EDs0 of cyclosporin A in this assay 
(1-2 #g/ml) is much lower than its LDs0 (,,o200/zg/ml), is 
directly proportional to CNA gene dosage, and is indepen- 
dent of FKBP-12. The effectiveness of both drugs can be ex- 
plained by a model where a growth inhibitory complex of 
Ca2÷/calmodulin/calcineurin forms in pmcl mutants during 
Cunningham and Fink Ca  z+ Transport and Signaling  in  Yeast  359 Figure 10. The synthetic lethality ofpmcl pmrl double mutants is reversed by a cnbl mutation or by addition of FK506. Strains K610 
(pmrl), K612 (pmrl cnbl), K614 (pmrlpmcl), and K616 (pmrlpmcl cnbl) were streaked onto YPD agar medium supplemented with FK506 
(0.4/zg/ml)  and/or CaCI2 (20 mM) as indicated.  The strains were initially recovered by germinating ascopores produced  from a triply 
heterozygous diploid on YPD+FK506+CaCI2 medium where all genotypes are viable. The colonies were photographed after 4 d of incu- 
bation at 30°C. The pmrl pmcl double mutants did not form visible colonies on YPD or YPD plus 20 mM CaC12. 
growth  in  high  Ca  2÷ media,  and  that  this  complex is  in- 
hibited by the stoichiometric binding of FK506/FKBP-12 or 
cyclosporin A/cyclophilin (Foor et al.,  1992).  This model 
implies that [Ca2+]c is elevated in pmcl mutants during in- 
cubation in high Ca  2+ media, in agreement with the genetic 
data  suggesting that Ca2+/calmodulin but not apo-calmod- 
ulin (as produced by cmdl-3) is required for the inhibitory 
effect of calcineurin. 
The Inviability  of a pmrl pmcl Double Mutant Is 
Suppressed by Inactivation of Calcineurin 
The  role  of PMC1 in  Ca  ~+  tolerance  may  be  shared  by 
PMRI (Rudolph et al., 1989; Antebi and Fink, 1992), a puta- 
tive  Ca  2+  ATPase  in  the  Golgi  complex  related  to  Ca  ~+ 
ATPases of the mammalian SERCA.  This possibility was 
verified by the observation that overexpression of PMRI in 
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Figure  11.  A  working  model  for  Ca  2+  transport  in  yeast  and 
Ca2+/calcineurin dependent inhibition of growth. The cytoplasmic 
pool of Ca  2+ is increased by influx of external Ca  2+ and decreased 
by sequestration activities of Pmclp  and  Pmrlp  which directly 
pump  Ca  2÷  into  the  vacuole  and  Golgi complex,  respectively. 
Other Ca  ~+ transporters  may also contribute to control of cyto- 
plasmic Ca  2+. Elevation of the cytosolic free Ca  2÷ concentration, 
[Ca2+]c, activates calcineurin by increasing the binding of Ca  2+ 
and calmodulin. Inappropriate activation of  calcineurin, attained by 
increased Ca  2÷ influx and/or decreased sequestration, dephosphor- 
ylates protein substrates whose phosphorylation is necessary for 
growth during these conditions. The downstream targets of cal- 
cineurin and their roles in growth control are unknown. It is possi- 
ble that calcineurin negatively regulates a Ca2+-sequestering mech- 
anism distinct from Pmclp (Fig. 5). 
pmcl mutants restores growth in high Ca  2÷ media (Fig.  8, 
lines 11 and 12).  Moreover, simultaneous deletion of both 
PMC1 and PMR1 causes a phenotype more severe than either 
mutation alone. Strains containing both pmrl pmcl null mu- 
tations are inviable on all media regardless of the external 
Ca  2÷ levels (from 0.2 to 200 mM). However, the lethality of 
pmrl pmcl strains is prevented by inactivation of calcineurin 
with either FK506 (400 ng/ml) or the crib1 null mutation 
(Fig. 10). Thus, PMC1 andPMR1 are redundant for an essen- 
tial function only when calcineurin can be activated, 
The simplest model consistent with  these findings  (see 
Fig. 11) is that both PMC1 and PMR1 gene products transport 
Ca  2÷  from  the  cytosol into  internal  compartments.  Ade- 
quate Ca  2÷ ATPase activity is essential for yeast growth in 
order to prevent the inhibitory activation of calcineurin by 
calmodulin in response to elevated [Ca2+]c. Calcineurin ac- 
tivation may inhibit growth ofpmcl mutants by a variety of 
mechanisms, such as decreasing the activity of  unknown fac- 
tors necessary for growth or Ca  2÷ tolerance. 
Discussion 
PMC1 Encodes a Vacuolar Ca  z÷  ATPase Involved in 
Ca  ~÷ Sequestration and Regulation of [Ca2÷]c 
Several lines  of evidence indicate  that  Pmclp  transports 
Ca  2÷ from the cytoplasm into the vacuole. First,  the pre- 
dicted product of PMC1 contains all the conserved features 
of P-type ion pumps and is highly homologous to mammalian 
PMCAs (41% identical through 81% of its sequence). Sec- 
ond, the phenotypes of pmcl mutants are consistent with a 
direct role for Pmclp in Ca  2+ transport. Although pmcl null 
mutants show no obvious growth or morphological pheno- 
types on standard media, they accumulate significantly less 
Ca  2÷ in the vacuole and are intolerant of high Ca  2÷ in the 
growth medium. Third, the behavior ofpmcl mutants is dra- 
matically affected by modifications of a Ca~÷-sensitive reg- 
ulatory pathway consisting of calmodulin and calcineurin. 
Finally, PMC1 shares  an essential function with PMRI,  a 
member of SERCA-type Ca  2÷ pumps (Serrano,  1991).  All 
these properties are consistent with a general model of Ca  2+ 
transport and signaling thought to exist in most eukaryotic 
cells (Fig.  11). However, the study of Ca  2÷ metabolism in 
yeast has revealed some noteworthy distinctions. 
Ca  2÷ uptake into the yeast vacuole in vitro is predomi- 
nantly due to low affinity H+/Ca  ~÷ antiport activity (Ohsumi 
and Anraku,  1983).  However, during growth in 0.18  mM 
Ca  ~+  YPD  medium  (Ohya et al.,  1984),  the  majority of 
Ca  ~+  sequestered in the vacuole requires Pmclp (Fig.  5). 
Thermodynamic considerations also argue that Ca  2+ ATP- 
ases are necessary to account for the high levels of Ca  ~+ se- 
questered in fungal vacuoles (Miller et al., 1990). In the ab- 
sence  of Pmclp,  the  residual  Ca  2+  sequestration  can  be 
attributed to the  vacuolar antiporter and/or Pmrlp  in the 
Golgi complex. PMR1 is required for viability ofpmcl mu- 
tants and overexpression of PMRI  restores Ca  2+ tolerance 
to  prad  mutants.  The  simplest  interpretation  of  these 
findings is that Pmclp and Pmrlp both transport Ca  2÷ from 
the  cytoplasm  into  internal  compartments  and  therefore 
function redundantly in controlling cytoplasmic Ca  2+ levels. 
This effect is not unlike the roles of PMCA and SERCA in 
returning [Ca2+]c to submicromolar levels after Ca  2+ influx 
is induced by external stimuli (Carafoli,  1987). The major 
distinction is that yeast utilize Pmclp for Ca  2÷ sequestration 
into the vacuole whereas mammalian cells utilize PMCA for 
Ca  2+ efflux through the plasma membrane. 
Calcineurin Activation by Caz+  /Calmodulin Is Growth 
Inhibitory in pmcl Mutants 
Our results show that the inviability ofpmcl strains in high 
Ca  2+ media requires calcineurin activation by Ca2+/calmod - 
ulin. The growth defects ofpmcl strains in high Ca  2+ media 
are completely reversed in strains lacking either the catalytic 
or regulatory subunits of calcineurin or in strains containing 
mutant  forms  of calmodulin  with  defective Ca  2+  binding 
sites. Expression of a truncated calcineurin A lacking the au- 
toinhibitory domain bypasses the requirement for Ca2+/cal  - 
modulin, preventing growth ofpmcl cmdl-3 double mutants 
in  high  Ca  2÷ medium.  These in  vivo data  are  consistent 
with the mechanism of calcineurin activation in vitro where 
maximal stimulation of  phosphopeptide phosphatase activity 
requires binding of Ca2÷/calmodulin to relieve autoinhibition 
by the COOH-terminal domain of the catalytic A  subunit. 
The clear effect  of  inactivating calcineurin inpmcl mutants 
was exploited here in a bioassay for potential antagonists of 
yeast calcineurin. The immunosuppressant drugs FK506 and 
cyclosporin A, together with their respective immunophilin 
binding proteins, form inactive complexes with yeast and 
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1992).  As  demonstrated here,  both  of these  compounds 
mimic the effect of calcineurin mutations, restoring growth 
to pmcl mutants in high Ca  2+ media. Moreover, the effec- 
tive dosages of these drugs decreased about twofold when the 
gene dosage of calcineurin A was reduced by half. These 
findings provide strong evidence that calcineurin is the direct 
target of FK506 and cyclosporin A in yeast cells. Based on 
these results, we propose that calcineurin activation occurs 
during incubation of pmcl mutants in high Ca  2+ media. 
Calcineurin activation also occurs in standard media in 
pmclpmrl double mutants, and therefore is not restricted to 
conditions  of high  external  Ca  2+.  Calcineurin-dependent 
growth inhibition can be observed in pmcl pmrl strains in 
media containing 0.18-200 mM Ca  ~÷. Because Pmclp and 
Pmrlp function in Ca  ~+ sequestration, their shared essential 
function (in  >0.18  mM  Ca  :÷)  is  most likely to maintain 
sufficiently low [Ca2+]c to prevent activation of calcineurin. 
Though growth inhibition by calcineurin activation was most 
evident in pmclpmrl and pmcl strains, it is possible that cal- 
cineurin inhibits growth of wild-type strains in response to 
high Ca  2÷ environments (Fig. 6) or in response to natural 
Ca  ~+  signals.  Transient  Ca  2÷  signals  might be  generated 
during some situations by the physiological modulation of 
Pmclp and Pmrlp activities or other Ca  2+ transporters. 
Calcineurin-dependent Signaling Pathways 
The results reported here suggest that calcineurin activation 
can have a net negative effect on growth, which itself might 
obscure other positive effects. A positive (growth enhancing) 
role for calcineurin in yeast has been observed in response 
to prolonged cell cycle arrest by mating pheromones (Cyert 
et al., 1991; Cyert and Thorner, 1992). The process of  recov- 
ery from pheromone arrest is inefficient in calcineurin mu- 
tants and in strains treated with FK506 or cyclosporin A 
(Foor et al.,  1992).  Thus, calcineurin activation can affect 
yeast proliferation in a positive or negative way depending 
on the circumstances. The net effect of activated calcineurin 
may be a consequence of differences in the activity or avail- 
ability of phosphoprotein substrates,  in the nature of the 
cytosolic Ca  2+  signal,  or possibly the input of additional 
regulatory signals. 
Calcineurin-dependent signaling in human cells can also 
have a net positive or negative effect depending upon the cell 
status. Cyclosporin A and FK506 can prevent activation and 
proliferation of mature T  cells, whereas these compounds 
block the induced suicide of immature T cells (Bierer et al., 
1991). The calcineurin-dependent inhibition of yeast growth 
reported here is reversible, occurs at many stages of the cell 
cycle, and is therefore distinct from the type of cell death ob- 
served in immature T cells. A more complete understanding 
of the different responses will require the identification of 
distinguishing calcineurin targets. 
Our results show that in pmcl mutants, calcineurin func- 
tion  decreases  tolerance  to  external  Ca  2÷  (Fig.  6)  and 
decreases sequestration of Ca  2+ into the nonexchangeable 
(vacuolar) pool (Fig. 5). It is unlikely that the latter effect is 
due to increased influx or decreased efflux of Ca  2÷ since 
both these models would predict decreased tolerance to ex- 
ternal Ca  2+. An alternative explanation is that another en- 
zyme involved in Ca  2÷ transport into the vacuole, such as 
the H+/Ca  2+ antiporter (Ohsumi and Anraku, 1983),  is neg- 
atively regulated by calcineurin. This explanation would also 
account for the calcineurin-dependent growth inhibition of 
pmcl mutants in high Ca  2+ conditions. 
Given  the  remarkable  interspecies  conservation of the 
mechanism by which calcineurin is activated and inhibited, 
it is plausible that the physiological roles of calcineurin are 
similar in human and yeast cells.  The bioassays reported 
here will be useful to identify the downstream targets and 
functions of yeast calcineurin as a  framework for under- 
standing Ca2+-signaling mechanisms and responses in hu- 
man cells. 
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